A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia

Clinical trial NCT07052006 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07052006
Sponsor: Halia Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Anemia in Myelodysplastic Syndromes

Start date: 2023-12-09
Primary completion: 2026-01-08
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.